Peninnah Oberdorfer

Chiang Mai University — Thailand

Medicine · Health Sciences

27h-index1.9kcitations88works9.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

HIV/AIDS Research and Interventions(22), Antibiotics Pharmacokinetics and Efficacy(17), Antibiotic Resistance in Bacteria(15), Pneumonia and Respiratory Infections(13), Pneumocystis jirovecii pneumonia detection and treatment(10)

Publications88 total

Decision-Making System for Extended Bacteremia Treatment in Patients with Hematologic Malignancy
INDONESIAN JOURNAL OF PHARMACY·2025Open Access
Treatment Outcomes and Associated Factors of Intravenous Colistin for Nosocomial Infections in Pediatric Patients: A Retrospective Study in a University Hospital in Thailand
The Pediatric Infectious Disease Journal·2024· 1 cited
High-Loading-Dose Colistin with Nebulized Administration for Carbapenem-Resistant Acinetobacter baumannii Pneumonia in Critically Ill Patients: A Retrospective Cohort Study
Antibiotics·2024· 17 citedOpen Access
Comparative effectiveness and mortality of colistin monotherapy versus colistin-fosfomycin combination therapy for the treatment of carbapenem-resistant Enterobacteriaceae (CRE) infections: A propensity score analysis
Journal of Infection and Public Health·2024· 27 citedOpen Access
<b>Risk Factors for Acute Kidney Injury in Patients Receiving Intravenous Colistin</b>
Pharmaceutical Sciences·2024· 1 citedOpen Access
Comparative Safety and Effectiveness of Heterologous CoronaVac–ChAdOx1 versus Homologous CoronaVac Vaccination in a Real-World Setting: A Retrospective Cohort Study
Vaccines·2023· 3 citedOpen Access
Safety and Tolerability of V114 Pneumococcal Vaccine in Infants: A Phase 3 Study
PEDIATRICS·2023· 9 cited
Short versus long course of colistin treatment for carbapenem-resistant A. baumannii in critically ill patients: A propensity score matching study
Journal of Infection and Public Health·2023· 57 citedOpen Access
A phase 3, multicenter, randomized, double-blind study to evaluate the interchangeability of V114, a 15-valent pneumococcal conjugate vaccine, and PCV13 with respect to safety, tolerability, and immunogenicity in healthy infants (PNEU-DIRECTION)
Vaccine·2022· 17 cited
Effectiveness and Nephrotoxicity of Loading Dose Colistin–Meropenem versus Loading Dose Colistin–Imipenem in the Treatment of Carbapenem-Resistant Acinetobacter baumannii Infection
Pharmaceutics·2022· 35 citedOpen Access
Factors Predicting Practices in Prevention of COVID-19 and Impacts among Population in Chiang Mai, Thailand
Medicina·2022· 4 citedOpen Access
The Thirty-Day Mortality Rate and Nephrotoxicity Associated With Trough Serum Vancomycin Concentrations During Treatment of Enterococcal Infections: A Propensity Score Matching Analysis
Frontiers in Pharmacology·2022· 21 citedOpen Access
Clinical Efficacy and Nephrotoxicity of the Loading Dose Colistin for the Treatment of Carbapenem-Resistant Acinetobacter baumannii in Critically Ill Patients
Pharmaceutics·2021· 51 citedOpen Access
Clinical and economic outcomes attributable to carbapenem-resistant Enterobacterales and delayed appropriate antibiotic therapy in hospitalized patients
Infection Control and Hospital Epidemiology·2021· 5 cited
1184. A Phase 3, Multicenter, Randomized, Double-blind Study to Evaluate the Interchangeability of V114 and Prevnar 13™ with Respect to Safety, Tolerability, and Immunogenicity in Healthy Infants (PNEU-DIRECTION)
Open Forum Infectious Diseases·2021· 6 citedOpen Access
A Monocentric Retrospective Study of AUC/MIC Ratio of Vancomycin Associated with Clinical Outcomes and Nephrotoxicity in Patients with Enterococcal Infections
Pharmaceutics·2021· 35 citedOpen Access
Short-Course Versus Long-Course Colistin for Treatment of Carbapenem-Resistant A.baumannii in Cancer Patient
Antibiotics·2021· 14 citedOpen Access
Immunogenicity and safety profiles of a new MAV/06 strain varicella vaccine in healthy children: A multinational, multicenter, randomized, double-blinded, active-controlled phase III study
Vaccine·2021· 12 cited
Clinical Efficacy and Nephrotoxicity of Colistin Alone versus Colistin Plus Vancomycin in Critically Ill Patients Infected with Carbapenem-Resistant Acinetobacter baumannii: A Propensity Score-Matched Analysis
Pharmaceutics·2021· 39 citedOpen Access
Efficacy of loading dose colistin versus carbapenems for treatment of extended spectrum beta lactamase producing Enterobacteriaceae
Scientific Reports·2021· 29 citedOpen Access
page 1 of 5Next →

Frequent Co-authors

Wasan Katip(19), Thanyawee Puthanakit(11), Virat Sirisanthana(11), Thira Sirisanthana(8), Suriyon Uitrakul(6), Ajaree Rayanakorn(6), Satja Issaranggoon na Ayuthaya(6), Noppadon Akarathum(5), Linda Aurpibul(5), Pope Kosalaraksa(5), Orawan Louthrenoo(3), Puntapong Taruangsri(3), Teerapong Nampuan(3), Learn−Han Lee(3), Kulkanya Chokephaibulkit(3), Torsak Bunupuradah(3), Rawiwan Hansudewechakul(3), Pagakrong Lumbiganon(3), Nia Kurniati(3), Kamarul Azahar Mohd Razali(3)